Iterum Therapeutics PLC - ESG Rating & Company Profile powered by AI
This dashboard contains a questions and answers table for Iterum Therapeutics PLC. Detailed Sustainability assessment of Iterum Therapeutics PLC can be reached by signing up for free. This page displays a free Environmental, Social and Governance analysis for Iterum Therapeutics PLC.
Iterum Therapeutics PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.6; made up of an environmental score of 5.3, social score of 6.4 and governance score of 8.0.
6.6
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 337 | Sonoma Pharmaceuticals Inc | 6.7 | High |
| 337 | Zhong Yuan Bio-Technology Holdings Ltd | 6.7 | High |
| 389 | Iterum Therapeutics PLC | 6.6 | High |
| 389 | Austar Lifesciences Ltd | 6.6 | High |
| 389 | Alligator Bioscience AB | 6.6 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Iterum Therapeutics PLC have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Iterum Therapeutics PLC disclose current and historical energy intensity?
Sign up for free to unlockDoes Iterum Therapeutics PLC report the average age of the workforce?
Sign up for free to unlockDoes Iterum Therapeutics PLC reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Iterum Therapeutics PLC disclose its ethnicity pay gap?
Sign up for free to unlockDoes Iterum Therapeutics PLC disclose cybersecurity risks?
Sign up for free to unlockDoes Iterum Therapeutics PLC offer flexible work?
Sign up for free to unlockDoes Iterum Therapeutics PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Iterum Therapeutics PLC disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Iterum Therapeutics PLC conduct supply chain audits?
Sign up for free to unlockDoes Iterum Therapeutics PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Iterum Therapeutics PLC conduct 360 degree staff reviews?
Sign up for free to unlockDoes Iterum Therapeutics PLC disclose the individual responsible for D&I?
Sign up for free to unlockDoes Iterum Therapeutics PLC disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Iterum Therapeutics PLC disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Iterum Therapeutics PLC disclose water use targets?
Sign up for free to unlockDoes Iterum Therapeutics PLC have careers partnerships with academic institutions?
Sign up for free to unlockDid Iterum Therapeutics PLC have a product recall in the last two years?
Sign up for free to unlockDoes Iterum Therapeutics PLC disclose incidents of discrimination?
Sign up for free to unlockDoes Iterum Therapeutics PLC allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Iterum Therapeutics PLC issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Iterum Therapeutics PLC disclose parental leave metrics?
Sign up for free to unlockDoes Iterum Therapeutics PLC disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Iterum Therapeutics PLC disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Iterum Therapeutics PLC disclose the pay ratio of women to men?
Sign up for free to unlockDoes Iterum Therapeutics PLC support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Iterum Therapeutics PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Iterum Therapeutics PLC reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Iterum Therapeutics PLC involved in embryonic stem cell research?
Sign up for free to unlockDoes Iterum Therapeutics PLC disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Iterum Therapeutics PLC disclose its waste policy?
Sign up for free to unlockDoes Iterum Therapeutics PLC report according to TCFD requirements?
Sign up for free to unlockDoes Iterum Therapeutics PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Iterum Therapeutics PLC disclose energy use targets?
Sign up for free to unlockDoes Iterum Therapeutics PLC disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Iterum Therapeutics PLC have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Iterum Therapeutics PLC
These potential risks are based on the size, segment and geographies of the company.
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.